back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2026-03-30 17:18 Tx date 2026-03-26 |
$GUD
Knight Therapeutics Inc. |
Zanqueta Coelho Peev, Cristiane
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-35,010.42
-4,938 vol $7.09 each |
9,724 | |
| Filed 2026-03-30 17:14 Tx date 2026-03-23 |
$GUD
Knight Therapeutics Inc. |
Dos Santos Dias, Henrique José
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-25,290.18
-3,867 vol $6.54 each |
12,133 | |
| Filed 2026-03-30 15:58 Tx date 2026-03-23 |
$GUD
Knight Therapeutics Inc. |
Dos Santos Dias, Henrique José
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-24,956.64
-3,816 vol $6.54 each |
16,000 | |
| Filed 2026-03-30 15:51 Tx date 2026-03-23 |
$GUD
Knight Therapeutics Inc. |
Dos Santos Dias, Henrique José
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$21,827
+3,816 vol $5.72 each |
19,816 | |
| Filed 2026-03-30 15:46 Tx date 2026-03-23 |
$GUD
Knight Therapeutics Inc. |
Dos Santos Dias, Henrique José
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-21,827.52
-3,816 vol $5.72 each |
28,987 | |
| Filed 2026-03-28 10:54 Tx date 2026-03-23 |
$GUD
Knight Therapeutics Inc. |
Ferlaino, Cynthia
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$50,236
+7,974 vol $6.30 each |
14,251 | |
| Filed 2026-03-28 10:53 Tx date 2026-03-23 |
$GUD
Knight Therapeutics Inc. |
Ferlaino, Cynthia
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
$50,236
+7,974 vol $6.30 each |
14,251 | |
| Filed 2026-03-27 19:05 Tx date 2026-03-23 |
$GUD
Knight Therapeutics Inc. |
Lopez, German
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
$41,050
+6,516 vol $6.30 each |
15,475 | |
| Filed 2026-03-27 19:03 Tx date 2026-03-23 |
$GUD
Knight Therapeutics Inc. |
Lopez, German
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$41,050
+6,516 vol $6.30 each |
15,475 | |
| Filed 2026-03-27 18:58 Tx date 2026-03-23 |
$GUD
Knight Therapeutics Inc. |
Lopez, German
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$48,216
+7,522 vol $6.41 each |
14,548 | |
| Filed 2026-03-27 18:56 Tx date 2026-03-23 |
$GUD
Knight Therapeutics Inc. |
Lopez, German
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
57 - Exercise of rights
|
$-24,871.25
-4,925 vol $5.05 each |
8,959 | |
| Filed 2026-03-27 18:53 Tx date 2026-03-23 |
$GUD
Knight Therapeutics Inc. |
Lopez, German
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
57 - Exercise of rights
|
$-24,871.25
-4,925 vol $5.05 each |
8,959 | |
| Filed 2026-03-27 18:49 Tx date 2026-03-23 |
$GUD
Knight Therapeutics Inc. |
Urrea Franco, Luz Tatiana
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
$45,164
+7,169 vol $6.30 each |
20,919 | |
| Filed 2026-03-27 18:47 Tx date 2026-03-23 |
$GUD
Knight Therapeutics Inc. |
Urrea Franco, Luz Tatiana
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$45,164
+7,169 vol $6.30 each |
20,919 | |
| Filed 2026-03-27 18:45 Tx date 2026-03-23 |
$GUD
Knight Therapeutics Inc. |
Urrea Franco, Luz Tatiana
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$56,202
+8,768 vol $6.41 each |
8,768 | |
| Filed 2026-03-27 18:43 Tx date 2026-03-23 |
$GUD
Knight Therapeutics Inc. |
Urrea Franco, Luz Tatiana
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
57 - Exercise of rights
|
$-27,154.93
-5,741 vol $4.73 each |
13,750 | |
| Filed 2026-03-27 18:42 Tx date 2026-03-23 |
$GUD
Knight Therapeutics Inc. |
Urrea Franco, Luz Tatiana
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
57 - Exercise of rights
|
$-27,154.93
-5,741 vol $4.73 each |
13,750 | |
| Filed 2026-03-27 18:38 Tx date 2026-03-23 |
$GUD
Knight Therapeutics Inc. |
Groleau, Melanie
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Unit
56 - Grant of rights
|
$37,491
+5,951 vol $6.30 each |
17,225 | |
| Filed 2026-03-27 18:36 Tx date 2026-03-23 |
$GUD
Knight Therapeutics Inc. |
Groleau, Melanie
5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$74,982
+11,902 vol $6.30 each |
34,451 | |
| Filed 2026-03-27 18:33 Tx date 2026-03-23 |
$GUD
Knight Therapeutics Inc. |
Groleau, Melanie
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$103,364
+16,407 vol $6.30 each |
50,123 |